JP2018113985A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018113985A5 JP2018113985A5 JP2018073677A JP2018073677A JP2018113985A5 JP 2018113985 A5 JP2018113985 A5 JP 2018113985A5 JP 2018073677 A JP2018073677 A JP 2018073677A JP 2018073677 A JP2018073677 A JP 2018073677A JP 2018113985 A5 JP2018113985 A5 JP 2018113985A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- gene
- editing protein
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261721302P | 2012-11-01 | 2012-11-01 | |
| US61/721,302 | 2012-11-01 | ||
| US201361785404P | 2013-03-14 | 2013-03-14 | |
| US61/785,404 | 2013-03-14 | ||
| US201361842874P | 2013-07-03 | 2013-07-03 | |
| US61/842,874 | 2013-07-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540833A Division JP6510416B2 (ja) | 2012-11-01 | 2013-11-01 | 細胞中でタンパク質を発現するための方法および生成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018113985A JP2018113985A (ja) | 2018-07-26 |
| JP2018113985A5 true JP2018113985A5 (enExample) | 2018-09-06 |
| JP6793146B2 JP6793146B2 (ja) | 2020-12-02 |
Family
ID=50628111
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540833A Active JP6510416B2 (ja) | 2012-11-01 | 2013-11-01 | 細胞中でタンパク質を発現するための方法および生成物 |
| JP2018073676A Active JP6890565B2 (ja) | 2012-11-01 | 2018-04-06 | 細胞中でタンパク質を発現するための方法および生成物 |
| JP2018073677A Active JP6793146B2 (ja) | 2012-11-01 | 2018-04-06 | 細胞中でタンパク質を発現するための方法および生成物 |
| JP2021027831A Active JP7436406B2 (ja) | 2012-11-01 | 2021-02-24 | 細胞中でタンパク質を発現するための方法および生成物 |
| JP2024018042A Pending JP2024056815A (ja) | 2012-11-01 | 2024-02-08 | 細胞中でタンパク質を発現するための方法および生成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015540833A Active JP6510416B2 (ja) | 2012-11-01 | 2013-11-01 | 細胞中でタンパク質を発現するための方法および生成物 |
| JP2018073676A Active JP6890565B2 (ja) | 2012-11-01 | 2018-04-06 | 細胞中でタンパク質を発現するための方法および生成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021027831A Active JP7436406B2 (ja) | 2012-11-01 | 2021-02-24 | 細胞中でタンパク質を発現するための方法および生成物 |
| JP2024018042A Pending JP2024056815A (ja) | 2012-11-01 | 2024-02-08 | 細胞中でタンパク質を発現するための方法および生成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (19) | US9447395B2 (enExample) |
| EP (2) | EP2914728B1 (enExample) |
| JP (5) | JP6510416B2 (enExample) |
| KR (4) | KR102121086B1 (enExample) |
| CN (1) | CN104769112A (enExample) |
| AU (3) | AU2013337651B2 (enExample) |
| BR (2) | BR122019025681B1 (enExample) |
| CA (2) | CA2890110C (enExample) |
| MX (2) | MX363017B (enExample) |
| RU (2) | RU2711249C2 (enExample) |
| WO (1) | WO2014071219A1 (enExample) |
Families Citing this family (126)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10347710B4 (de) | 2003-10-14 | 2006-03-30 | Johannes-Gutenberg-Universität Mainz | Rekombinante Impfstoffe und deren Verwendung |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| EP4108671B1 (en) | 2010-10-01 | 2024-11-20 | ModernaTX, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| US8710200B2 (en) | 2011-03-31 | 2014-04-29 | Moderna Therapeutics, Inc. | Engineered nucleic acids encoding a modified erythropoietin and their expression |
| ES2746233T3 (es) | 2011-05-24 | 2020-03-05 | Biontech Rna Pharmaceuticals Gmbh | Vacunas individualizadas para el cáncer |
| US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| ES2911677T3 (es) | 2011-10-03 | 2022-05-20 | Modernatx Inc | Nucleósidos, nucleótidos y ácidos nucleicos modificados, y sus usos |
| MX2014007233A (es) | 2011-12-16 | 2015-02-04 | Moderna Therapeutics Inc | Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados. |
| WO2013143555A1 (en) | 2012-03-26 | 2013-10-03 | Biontech Ag | Rna formulation for immunotherapy |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| WO2013151663A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| WO2013163628A2 (en) | 2012-04-27 | 2013-10-31 | Duke University | Genetic correction of mutated genes |
| JP2015529685A (ja) | 2012-09-17 | 2015-10-08 | ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルＴｈｅ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ａｔｎａｔｉｏｎｗｉｄｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ | 筋萎縮性側索硬化症の処置のための組成物および方法 |
| WO2014071219A1 (en) | 2012-11-01 | 2014-05-08 | Factor Bioscience Inc. | Methods and products for expressing proteins in cells |
| PT2922554T (pt) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Arn modificado nas porções terminais |
| CA2892391C (en) | 2012-11-28 | 2023-10-17 | Biontech Rna Pharmaceuticals Gmbh | Individualized vaccines for cancer |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| US9828582B2 (en) | 2013-03-19 | 2017-11-28 | Duke University | Compositions and methods for the induction and tuning of gene expression |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| ES2991293T3 (es) * | 2013-06-05 | 2024-12-03 | Univ Duke | Edición génica guiada por ARN y regulación génica |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| EP4219727A3 (en) * | 2013-08-27 | 2023-09-06 | Research Institute at Nationwide Children's Hospital | Products and methods for treatment of amyotrophic lateral sclerosis |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
| WO2015051214A1 (en) | 2013-10-03 | 2015-04-09 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
| WO2015069647A1 (en) | 2013-11-05 | 2015-05-14 | The Research Institute At Nationwide Children's Hospital | COMPOSITIONS AND METHODS FOR INHIBITING NF- kB AND SOD-1 TO TREAT AMYOTROPHIC LATERAL SCLEROSIS |
| EP4372090A3 (en) | 2013-11-07 | 2024-08-07 | Editas Medicine, Inc. | Crispr-related methods and compositions with governing grnas |
| US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
| EP3116533B1 (en) * | 2014-03-12 | 2020-08-12 | Precision Biosciences, Inc. | Dystrophin gene exon deletion using engineered nucleases |
| PT3134131T (pt) | 2014-04-23 | 2022-03-24 | Modernatx Inc | Vacinas de ácidos nucleicos |
| CA2948429A1 (en) | 2014-05-09 | 2015-11-12 | Universite Laval | Prevention and treatment of alzheimer's disease by genome editing using the crispr/cas system |
| EP4079847A1 (en) | 2014-07-30 | 2022-10-26 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| WO2016045732A1 (en) | 2014-09-25 | 2016-03-31 | Biontech Rna Pharmaceuticals Gmbh | Stable formulations of lipids and liposomes |
| US10370673B2 (en) | 2014-09-26 | 2019-08-06 | Purecircle Sdn Bhd | Single nucleotide polymorphism (SNP) markers for stevia |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| PL3223846T3 (pl) * | 2014-11-26 | 2024-03-11 | Huvepharma, Inc. | Kompozycje adiuwantowe i powiązane sposoby |
| US10195261B2 (en) | 2014-11-26 | 2019-02-05 | VaxLiant, LLC | Adjuvant compositions and related methods |
| KR102763527B1 (ko) | 2014-12-03 | 2025-02-05 | 애질런트 테크놀로지스, 인크. | 화학적 변형을 갖는 가이드 rna |
| JP6929791B2 (ja) | 2015-02-09 | 2021-09-01 | デューク ユニバーシティ | エピゲノム編集のための組成物および方法 |
| WO2016128060A1 (en) | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| EP4406585A3 (en) * | 2015-02-13 | 2024-10-23 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
| AU2016235059B2 (en) | 2015-03-24 | 2021-04-01 | Huvepharma, Inc. | Adjuvant compositions and related methods |
| KR102648489B1 (ko) | 2015-04-06 | 2024-03-15 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna |
| ES3009026T3 (en) | 2015-07-22 | 2025-03-25 | Univ Duke | High-throughput screening of regulatory element function with epigenome editing technologies |
| CN108025074A (zh) * | 2015-07-25 | 2018-05-11 | 哈比卜·弗罗斯特 | 用于为癌症和其他病理状态提供治疗或治愈的系统、装置和方法 |
| JP6905755B2 (ja) | 2015-08-25 | 2021-07-21 | デューク ユニバーシティ | Ｒｎａガイド型エンドヌクレアーゼを使用してゲノム工学における特異性を改善する組成物および方法 |
| WO2017059902A1 (en) | 2015-10-07 | 2017-04-13 | Biontech Rna Pharmaceuticals Gmbh | 3' utr sequences for stabilization of rna |
| EP4089175A1 (en) | 2015-10-13 | 2022-11-16 | Duke University | Genome engineering with type i crispr systems in eukaryotic cells |
| US20190218546A1 (en) | 2015-10-16 | 2019-07-18 | Modernatx, Inc. | Mrna cap analogs with modified phosphate linkage |
| US11866754B2 (en) | 2015-10-16 | 2024-01-09 | Modernatx, Inc. | Trinucleotide mRNA cap analogs |
| IL294014B2 (en) | 2015-10-23 | 2024-07-01 | Harvard College | Nucleobase editors and uses thereof |
| CA3011692A1 (en) * | 2015-11-23 | 2017-06-01 | The Regents Of The University Of Colorado, A Body Corporate | Methods and compositions for reprogramming cells |
| EA201891317A3 (ru) | 2015-11-30 | 2019-04-30 | Дьюк Юниверсити | Терапевтические мишени для коррекции гена дистрофина человека с помощью редактирования генов и способы их применения |
| CN105494263B (zh) * | 2015-12-25 | 2018-11-30 | 哈尔滨医科大学 | 一种产生ho-1/app/psen1三转基因阿尔茨海默病小鼠模型的方法 |
| WO2017134529A1 (en) * | 2016-02-02 | 2017-08-10 | Crispr Therapeutics Ag | Materials and methods for treatment of severe combined immunodeficiency (scid) or omenn syndrome |
| US20190112353A1 (en) * | 2016-02-18 | 2019-04-18 | Crispr Therapeutics Ag | Materials and methods for treatment of severe combined immunodeficiency (scid) or omenn syndrome |
| US11530253B2 (en) | 2016-02-25 | 2022-12-20 | The Children's Medical Center Corporation | Customized class switch of immunoglobulin genes in lymphoma and hybridoma by CRISPR/CAS9 technology |
| US11083799B2 (en) | 2016-03-16 | 2021-08-10 | Crispr Therapeutics Ag | Materials and methods for treatment of hereditary haemochromatosis |
| WO2017167910A1 (en) * | 2016-03-31 | 2017-10-05 | Ethris Gmbh | Novel minimal utr sequences |
| EP3443081A4 (en) | 2016-04-13 | 2019-10-30 | Duke University | CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE |
| WO2017181107A2 (en) * | 2016-04-16 | 2017-10-19 | Ohio State Innovation Foundation | Modified cpf1 mrna, modified guide rna, and uses thereof |
| US10767175B2 (en) | 2016-06-08 | 2020-09-08 | Agilent Technologies, Inc. | High specificity genome editing using chemically modified guide RNAs |
| AU2017295720B2 (en) | 2016-07-13 | 2021-07-22 | Vertex Pharmaceuticals Incorporated | Methods, compositions and kits for increasing genome editing efficiency |
| US12214056B2 (en) | 2016-07-19 | 2025-02-04 | Duke University | Therapeutic applications of CPF1-based genome editing |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
| WO2018035377A1 (en) | 2016-08-17 | 2018-02-22 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
| CN106370765A (zh) * | 2016-08-23 | 2017-02-01 | 国家烟草质量监督检验中心 | 一种基于反相色谱飞行时间质谱的喉癌尿液差异代谢物的测定筛选方法 |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| CN106381310B (zh) * | 2016-08-31 | 2020-02-04 | 武汉华美生物工程有限公司 | 一种用t7噬菌体rna聚合酶和t7启动子系统在哺乳动物细胞表达蛋白的方法 |
| SG11201903089RA (en) | 2016-10-14 | 2019-05-30 | Harvard College | Aav delivery of nucleobase editors |
| EP3538075A4 (en) * | 2016-11-11 | 2020-08-05 | Dnalite Therapeutics, Inc. | GENE THERAPY STRUCTURES AND PROCESSES |
| KR101908593B1 (ko) * | 2016-12-07 | 2018-10-16 | 연세대학교 산학협력단 | Cftr 유전자 소실 유도 가이드 rna, cftr 변이를 갖는 t84 세포 및 이의 용도 |
| US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
| US20200040061A1 (en) * | 2017-02-22 | 2020-02-06 | Crispr Therapeutics Ag | Materials and methods for treatment of early onset parkinson's disease (park1) and other synuclein, alpha (snca) gene related conditions or disorders |
| US11168319B1 (en) * | 2017-02-28 | 2021-11-09 | Inari Agriculture Technology, Inc. | Plant cell culture |
| US11407800B2 (en) * | 2017-02-28 | 2022-08-09 | Arcturus Therapeutics, Inc. | Translatable molecules and synthesis thereof |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| EP3592381A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Cancer vaccine |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| CN107475255B (zh) * | 2017-03-21 | 2021-03-26 | 河北医科大学第二医院 | 一种基因载体介导的基于CRISPR/Cas9基因编辑系统的sgRNA及其用途 |
| GB2575930A (en) | 2017-03-23 | 2020-01-29 | Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
| WO2018204786A1 (en) | 2017-05-05 | 2018-11-08 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| WO2018209320A1 (en) | 2017-05-12 | 2018-11-15 | President And Fellows Of Harvard College | Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation |
| WO2018224166A1 (en) | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy |
| US11002729B2 (en) * | 2017-06-14 | 2021-05-11 | Wuhan Institute Of Virology, Chinese Academy Of Sciences | CD2-associated protein (CD2AP) and its interactive proteins |
| US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| US11434502B2 (en) | 2017-10-16 | 2022-09-06 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (ALS) |
| WO2019079347A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | USES OF BASIC EDITORS ADENOSINE |
| WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| WO2019144124A1 (en) | 2018-01-22 | 2019-07-25 | Inari Agriculture, Inc. | Plant gene editing systems, methods, and compositions |
| WO2019191341A1 (en) * | 2018-03-27 | 2019-10-03 | Factor Bioscience Inc. | Nucleic acid-based therapeutics |
| WO2019204643A2 (en) | 2018-04-18 | 2019-10-24 | Altius Institute For Biomedical Sciences | Animal pathogen-derived polypeptides and uses thereof for genetic engineering |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| CN108624592B (zh) * | 2018-05-24 | 2021-08-17 | 苏州大学张家港工业技术研究院 | 针对DJ-1基因编辑的sgRNA筛选及其载体与应用 |
| CA3104673A1 (en) * | 2018-06-27 | 2020-01-02 | Modernatx, Inc. | Personalized cancer vaccine epitope selection |
| US12264181B2 (en) | 2018-06-27 | 2025-04-01 | Altius Institute For Biomedical Sciences | Nucleic acid binding domains and methods of use thereof |
| CN108949830B (zh) * | 2018-08-03 | 2021-11-26 | 福州大学 | 一种在鱼类中实现基因组编辑、精确定点基因敲入的方法 |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| CN109628404B (zh) * | 2018-12-18 | 2020-04-28 | 浙江大学 | 猪皮下脂肪前体细胞永生化细胞系的构建方法及用途 |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| DE112020001342T5 (de) | 2019-03-19 | 2022-01-13 | President and Fellows of Harvard College | Verfahren und Zusammensetzungen zum Editing von Nukleotidsequenzen |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| CN110200973A (zh) * | 2019-06-19 | 2019-09-06 | 南京市儿童医院 | Dna依赖性蛋白激酶特异性抑制剂在制备防治肾纤维化药物中的用途 |
| AU2020301036A1 (en) | 2019-07-03 | 2022-02-17 | Factor Bioscience Inc. | Cationic lipids and uses thereof |
| US11746354B2 (en) | 2019-07-19 | 2023-09-05 | Inari Agriculture Technology, Inc. | Homology dependent repair genome editing |
| US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
| CN110699381A (zh) * | 2019-09-17 | 2020-01-17 | 合肥瑞灵生物科技有限公司 | 地中海贫血病基因治疗载体构建方法及其用途 |
| WO2021072328A1 (en) | 2019-10-10 | 2021-04-15 | The Broad Institute, Inc. | Methods and compositions for prime editing rna |
| US20210290757A1 (en) | 2020-03-23 | 2021-09-23 | Avectas Limited | Engineering of dendritic cells for generation of vaccines against sars-cov-2 |
| GB2614813B (en) | 2020-05-08 | 2025-05-07 | Harvard College | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| CN113151181B (zh) * | 2021-04-14 | 2022-11-29 | 中山大学附属第七医院(深圳) | 一种脂肪干细胞重编程为神经元的方法及负载该神经元的细胞适应性水凝胶修复脊髓损伤 |
| CN113373214B (zh) * | 2021-06-18 | 2024-03-29 | 中国人民解放军军事科学院军事医学研究院 | Cd30在诊断脑神经相关疾病中的用途 |
| KR20240055811A (ko) | 2021-09-10 | 2024-04-29 | 애질런트 테크놀로지스, 인크. | 프라임 편집을 위한 화학적 변형을 갖는 가이드 rna |
| CN114150017B (zh) * | 2021-11-30 | 2023-05-16 | 长江大学 | 一种调节猪未成熟睾丸支持细胞乳酸分泌水平的方法及应用 |
| CN119731321A (zh) | 2022-06-24 | 2025-03-28 | 图恩疗法股份有限公司 | 通过靶向基因阻遏减少低密度脂蛋白的组合物、系统和方法 |
| WO2024032678A1 (zh) * | 2022-08-11 | 2024-02-15 | 益杰立科(上海)生物科技有限公司 | 一种表观编辑靶点的方法及用途 |
| KR20250057640A (ko) * | 2023-10-18 | 2025-04-29 | 연세대학교 산학협력단 | 신경세포 분화 유도용 재조합 벡터 및 이를 포함하는 퇴행성 뇌신경 질환의 예방 또는 치료용 약학적 조성물 |
| CN118667815B (zh) * | 2024-07-16 | 2025-02-14 | 宁夏大学 | 一种靶向prdm1改善牛子宫内膜炎的核苷酸序列及其应用 |
Family Cites Families (123)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3539465A (en) | 1968-10-08 | 1970-11-10 | Ncr Co | Encapsulation of hydrophilic liquid-in-oil emulsions |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US6743771B2 (en) * | 1995-12-29 | 2004-06-01 | Novactyl, Inc. | Methods and compositions for controlling protein assembly or aggregation |
| CA2277278A1 (en) | 1997-01-10 | 1998-07-16 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| EP1021549A2 (en) | 1997-09-19 | 2000-07-26 | Sequitur, Inc. | SENSE mRNA THERAPY |
| US20110171185A1 (en) | 1999-06-30 | 2011-07-14 | Klimanskaya Irina V | Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof |
| US7621606B2 (en) | 2001-08-27 | 2009-11-24 | Advanced Cell Technology, Inc. | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
| KR100894767B1 (ko) | 2000-09-26 | 2009-04-24 | 이데라 파마슈티칼즈, 인코포레이티드 | 화학적인 위치 변화에 의해 면역자극 올리고누클레오티드유사체의 면역자극 활성을 조절하는 방법 |
| EP1437403A4 (en) | 2001-09-21 | 2004-10-27 | Japan Science & Tech Corp | METHOD FOR PATTERNING REPROGRAMMING FACTOR, METHOD OF PATTERNED REPROGRAMMING FACTOR, METHOD FOR USE OF REPROGRAMMING FACTOR, METHOD FOR DIFFERENTIATING AND SIFE-INGENATING FAN |
| CA2463914A1 (en) | 2001-10-18 | 2003-04-24 | Ixion Biotechnology, Inc. | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| US7276489B2 (en) | 2002-10-24 | 2007-10-02 | Idera Pharmaceuticals, Inc. | Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| GB0202149D0 (en) | 2002-01-30 | 2002-03-20 | Univ Edinburgh | Pluripotency determining factors and uses thereof |
| US7541344B2 (en) | 2003-06-03 | 2009-06-02 | Eli Lilly And Company | Modulation of survivin expression |
| US7682828B2 (en) | 2003-11-26 | 2010-03-23 | Whitehead Institute For Biomedical Research | Methods for reprogramming somatic cells |
| EP1791948B1 (en) | 2004-09-08 | 2012-03-14 | Wisconsin Alumni Research Foundation | Medium and culture of embryonic stem cells |
| BRPI0514641A (pt) | 2004-09-08 | 2008-06-17 | Wisconsin Alumni Res Found | cultivação das células tronco embriÈnica humana |
| AU2006208199B2 (en) * | 2005-01-25 | 2012-06-07 | Cell Therapeutics, Inc. | Conjugates of biologically active proteins having a modified in vivo half-life |
| US7696318B2 (en) * | 2005-07-13 | 2010-04-13 | Novo Nordisk Health Care Ag | Host cell protein knock-out cells for production of therapeutic proteins |
| SG10201508995QA (en) * | 2005-07-26 | 2015-11-27 | Sangamo Biosciences Inc | Targeted integration and expression of exogenous nucleic acid sequences |
| US8323666B2 (en) | 2005-08-01 | 2012-12-04 | Allergan, Inc. | Botulinum toxin compositions |
| LT2578685T (lt) | 2005-08-23 | 2019-06-10 | The Trustees Of The University Of Pennsylvania | Rnr, apimančios modifikuotus nukleozidus ir jų panaudojimo būdai |
| US9012219B2 (en) | 2005-08-23 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | RNA preparations comprising purified modified RNA for reprogramming cells |
| US8476070B2 (en) | 2005-08-29 | 2013-07-02 | Technion Research & Development Foundation Limited | Media for culturing stem cells |
| WO2007069666A1 (ja) | 2005-12-13 | 2007-06-21 | Kyoto University | 核初期化因子 |
| US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
| US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
| US20100168000A1 (en) | 2005-12-22 | 2010-07-01 | Peter Kiessling | Octanoate-Reduced Human Albumin |
| DE102006051516A1 (de) * | 2006-10-31 | 2008-05-08 | Curevac Gmbh | (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins |
| GB0623635D0 (en) | 2006-11-27 | 2007-01-03 | Stem Cell Sciences Uk Ltd | Pluripotent cell growth media |
| CA2671850A1 (en) | 2006-12-08 | 2008-06-19 | Massachusetts Institute Of Technology | Delivery of nanoparticles and/or agents to cells |
| US10829733B2 (en) | 2007-01-04 | 2020-11-10 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| EP2099911A2 (en) | 2007-01-11 | 2009-09-16 | Yale University | Compositions and methods for targeted inactivation of hiv cell surface receptors |
| US8859229B2 (en) | 2007-02-02 | 2014-10-14 | Yale University | Transient transfection with RNA |
| US9249423B2 (en) | 2007-02-02 | 2016-02-02 | Yale University | Method of de-differentiating and re-differentiating somatic cells using RNA |
| SG193652A1 (en) | 2007-03-23 | 2013-10-30 | Wisconsin Alumni Res Found | Somatic cell reprogramming |
| EP3878949B1 (en) | 2007-04-07 | 2025-06-04 | Whitehead Institute for Biomedical Research | Reprogramming of somatic cells |
| JP5558097B2 (ja) | 2007-12-10 | 2014-07-23 | 国立大学法人京都大学 | 効率的な核初期化方法 |
| EP2072618A1 (en) | 2007-12-14 | 2009-06-24 | Johannes Gutenberg-Universität Mainz | Use of RNA for reprogramming somatic cells |
| CN102027105B (zh) | 2008-03-17 | 2015-03-11 | 斯克里普斯研究所 | 用于产生诱导的多能干细胞的组合化学遗传方法 |
| US20110045001A1 (en) | 2008-03-28 | 2011-02-24 | Biontex Laboratories Gmbh | Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| JP2011518555A (ja) * | 2008-04-14 | 2011-06-30 | サンガモ バイオサイエンシーズ， インコーポレイテッド | 標的組込みのための線形ドナーコンストラクト |
| WO2009127230A1 (en) | 2008-04-16 | 2009-10-22 | Curevac Gmbh | MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION |
| DK2297307T3 (en) | 2008-06-04 | 2016-07-25 | Cellular Dynamics Int Inc | PROCEDURES FOR THE MANUFACTURE OF IPS CELLS USING NON-VIRAL METHODS |
| GB2460552B (en) | 2008-06-05 | 2011-09-07 | Iti Scotland Ltd | Stem cell culture media and methods |
| US8669048B2 (en) | 2008-06-24 | 2014-03-11 | Parkinson's Institute | Pluripotent cell lines and methods of use thereof |
| US20100184033A1 (en) | 2008-07-16 | 2010-07-22 | West Michael D | Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby |
| EP2326711A2 (en) | 2008-08-20 | 2011-06-01 | VIRxSYS Corporation | Compositions and methods for generation of pluripotent stem cells |
| CN105802917A (zh) | 2008-10-24 | 2016-07-27 | 威斯康星校友研究基金会 | 通过非病毒重编程获得的多潜能干细胞 |
| ES2561949T3 (es) | 2008-11-21 | 2016-03-01 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Reprogramación de células hacia un estado pluripotente |
| US20110023141A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Genomic editing of genes involved with parkinson's disease |
| WO2010079340A2 (en) | 2009-01-08 | 2010-07-15 | Eisai R & D Management Co., Ltd. | Assay |
| EP2206723A1 (en) * | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
| US20110239315A1 (en) | 2009-01-12 | 2011-09-29 | Ulla Bonas | Modular dna-binding domains and methods of use |
| US8219348B2 (en) | 2009-01-22 | 2012-07-10 | Johnson Controls Technology Company | Method for calibrating and/or correcting a display device having a needle, the needle being able to move in rotation about an axis of rotation |
| WO2010093655A2 (en) | 2009-02-10 | 2010-08-19 | University Of Dayton | Enhanced method for producing stem-like cells from somatic cells |
| US10894944B2 (en) | 2009-04-10 | 2021-01-19 | Monash University | Cell culture media |
| EP3904505A1 (en) | 2009-04-22 | 2021-11-03 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| US10837020B2 (en) | 2009-04-22 | 2020-11-17 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long RNA molecules |
| US20100273220A1 (en) | 2009-04-22 | 2010-10-28 | Massachusetts Institute Of Technology | Innate immune suppression enables repeated delivery of long rna molecules |
| US8496941B2 (en) | 2009-06-03 | 2013-07-30 | National Institute Of Advanced Industrial Science And Technology | Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same |
| KR20140119197A (ko) * | 2009-07-31 | 2014-10-08 | 에트리스 게엠베하 | 단백질 발현을 위한 비변형된 뉴클레오티드 및 변형된 뉴클레오티드의 조합을 가진 ｒｎａ |
| US8586526B2 (en) * | 2010-05-17 | 2013-11-19 | Sangamo Biosciences, Inc. | DNA-binding proteins and uses thereof |
| EP2480659A2 (en) * | 2009-09-24 | 2012-08-01 | Cellectis | Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations |
| WO2011050470A1 (en) * | 2009-10-29 | 2011-05-05 | Mcmaster University | Generating induced pluripotent stem cells and progenitor cells from fibroblasts |
| US9295697B2 (en) | 2009-11-04 | 2016-03-29 | Cellular Dynamics International, Inc. | Episomal reprogramming with chemicals |
| CN102712904A (zh) | 2009-11-11 | 2012-10-03 | 桑福德—伯恩哈姆医学研究协会 | 用于产生和调节iPS细胞的方法及其组合物 |
| US8808982B2 (en) | 2009-12-07 | 2014-08-19 | Cellscript, Llc | Compositions and methods for reprogramming eukaryotic cells |
| US20130189741A1 (en) | 2009-12-07 | 2013-07-25 | Cellscript, Inc. | Compositions and methods for reprogramming mammalian cells |
| US8586363B2 (en) * | 2009-12-10 | 2013-11-19 | Regents Of The University Of Minnesota | TAL effector-mediated DNA modification |
| US8557972B2 (en) | 2009-12-21 | 2013-10-15 | University Of Washington Through Its Center For Commercialization | Compositions and methods for transfection of RNA and controlled stabilization of transfected RNA |
| CA2788635A1 (en) | 2010-02-01 | 2011-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced efficiency of induced pluripotent stem cell generation |
| WO2011110886A1 (en) | 2010-03-09 | 2011-09-15 | Biolamina Ab | Composition and method for enabling proliferation of pluripotent human stem cells |
| CA3122219A1 (en) | 2010-04-16 | 2011-10-20 | The Children's Hospital Corporation | Sustained polypeptide expression from synthetic, modified rnas and uses thereof |
| US9725695B2 (en) | 2010-05-05 | 2017-08-08 | The Regents Of The University Of California | Stem cell defined media for xeno-free and feeder free conditions and uses thereof |
| CA2799095A1 (en) * | 2010-05-12 | 2011-11-17 | Cellectis | Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof |
| US8048675B1 (en) | 2010-05-12 | 2011-11-01 | Ipierian, Inc. | Integration-free human induced pluripotent stem cells from blood |
| EP2392208B1 (en) * | 2010-06-07 | 2016-05-04 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| EP2580331A4 (en) * | 2010-06-14 | 2013-11-27 | Univ Iowa State Res Found Inc | NUCLEASE ACTIVITY OF THE TAL EFFECTOR AND FUSION PROTEIN FOKI |
| CN103003416B (zh) * | 2010-06-15 | 2016-11-16 | 细胞动力学国际有限公司 | 从小体积的外周血产生诱导性多潜能干细胞 |
| CA2807418C (en) | 2010-08-05 | 2017-04-04 | Wisconsin Alumni Research Foundation | Simplified basic media for human pluripotent cell culture |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| US20140127814A1 (en) | 2010-08-10 | 2014-05-08 | Srinivasan Chandrasegaran | Generation and use of pluripotent stem cells |
| GB201014169D0 (en) * | 2010-08-25 | 2010-10-06 | Cambridge Entpr Ltd | In vitro hepatic differentiation |
| US9447408B2 (en) | 2010-09-14 | 2016-09-20 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
| AU2011312562B2 (en) * | 2010-09-27 | 2014-10-09 | Sangamo Therapeutics, Inc. | Methods and compositions for inhibiting viral entry into cells |
| EP4108671B1 (en) | 2010-10-01 | 2024-11-20 | ModernaTX, Inc. | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| WO2012048213A1 (en) * | 2010-10-08 | 2012-04-12 | Regents Of The University Of Minnesota | A method to increase gene targeting frequency |
| US9637732B2 (en) | 2010-11-04 | 2017-05-02 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
| WO2012094132A1 (en) * | 2011-01-05 | 2012-07-12 | Sangamo Biosciences, Inc. | Methods and compositions for gene correction |
| US9499592B2 (en) * | 2011-01-26 | 2016-11-22 | President And Fellows Of Harvard College | Transcription activator-like effectors |
| KR20120096395A (ko) * | 2011-02-22 | 2012-08-30 | 주식회사 툴젠 | 뉴클레아제에 의해 유전자 변형된 세포를 농축시키는 방법 |
| EP3461898A1 (en) * | 2011-02-25 | 2019-04-03 | The University Court Of The University of Edinburgh | Genetically modified animals and methods for making the same |
| AU2012225497A1 (en) | 2011-03-07 | 2013-10-24 | Massachusetts Institute Of Technology | Methods for transfecting cells with nucleic acids |
| US8710200B2 (en) | 2011-03-31 | 2014-04-29 | Moderna Therapeutics, Inc. | Engineered nucleic acids encoding a modified erythropoietin and their expression |
| EP2694660B1 (en) | 2011-04-03 | 2018-08-08 | The General Hospital Corporation | Efficient protein expression in vivo using modified rna (mod-rna) |
| WO2012138927A2 (en) * | 2011-04-05 | 2012-10-11 | Philippe Duchateau | Method for the generation of compact tale-nucleases and uses thereof |
| US9862926B2 (en) | 2011-06-27 | 2018-01-09 | Cellscript, Llc. | Inhibition of innate immune response |
| EP2732029B1 (en) | 2011-07-11 | 2019-01-16 | FUJIFILM Cellular Dynamics, Inc. | Methods for cell reprogramming and genome engineering |
| CA3186126A1 (en) * | 2011-09-21 | 2013-03-28 | Sangamo Biosciences, Inc. | Methods and compositions for regulation of transgene expression |
| ES2911677T3 (es) | 2011-10-03 | 2022-05-20 | Modernatx Inc | Nucleósidos, nucleótidos y ácidos nucleicos modificados, y sus usos |
| US8497124B2 (en) | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| KR20250035015A (ko) * | 2011-12-05 | 2025-03-11 | 팩터 바이오사이언스 인크. | 세포를 형질감염시키는 방법들 및 생성물들 |
| MX2014007233A (es) | 2011-12-16 | 2015-02-04 | Moderna Therapeutics Inc | Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados. |
| EP2793906A4 (en) | 2011-12-21 | 2016-01-13 | Moderna Therapeutics Inc | METHOD FOR INCREASING THE LIFE-LIFE OR DURABILITY OF AN ORGAN OR ORGAN EXPLOITATE |
| DK3421601T3 (da) | 2011-12-30 | 2020-02-24 | Cellscript Llc | Fremstilling og anvendelse af in-vitro-syntetiseret ssRNA til indføring i pattedyrceller med henblik på at inducere en biologisk eller biokemisk effekt |
| WO2013151663A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| US20130274129A1 (en) * | 2012-04-04 | 2013-10-17 | Geneart Ag | Tal-effector assembly platform, customized services, kits and assays |
| EP2836501B1 (en) | 2012-04-10 | 2018-03-07 | City of Hope | Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells |
| CN104718283A (zh) | 2012-04-24 | 2015-06-17 | 布里格姆及妇女医院股份有限公司 | 从头生成多能细胞 |
| US9738879B2 (en) * | 2012-04-27 | 2017-08-22 | Duke University | Genetic correction of mutated genes |
| ES2951822T3 (es) | 2012-05-13 | 2023-10-25 | Allele Biotechnology & Pharmaceuticals Inc | Derivación sin alimentadores de células madre pluripotentes inducidas humanas con ARN mensajero sintético |
| US10119150B2 (en) | 2012-05-13 | 2018-11-06 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| US10155929B2 (en) | 2012-05-13 | 2018-12-18 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| ES2697912T3 (es) * | 2012-07-11 | 2019-01-29 | Sangamo Therapeutics Inc | Métodos y composiciones para el tratamiento de enfermedades monogénicas |
| EP2684892A1 (en) * | 2012-07-13 | 2014-01-15 | Association Française contre les Myopathies | Compositions and methods for duchenne muscular dystrophy gene therapy |
| WO2014059173A2 (en) * | 2012-10-10 | 2014-04-17 | Sangamo Biosciences, Inc. | T cell modifying compounds and uses thereof |
| WO2014071219A1 (en) * | 2012-11-01 | 2014-05-08 | Factor Bioscience Inc. | Methods and products for expressing proteins in cells |
| US20140140969A1 (en) * | 2012-11-20 | 2014-05-22 | Sangamo Biosciences, Inc. | Methods and compositions for muscular dystrophies |
| US9255250B2 (en) * | 2012-12-05 | 2016-02-09 | Sangamo Bioscience, Inc. | Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene |
| SI2959005T1 (sl) | 2013-02-22 | 2022-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Medicinska uporaba v zvezi z ekstenzijo telomera |
| ES2991293T3 (es) * | 2013-06-05 | 2024-12-03 | Univ Duke | Edición génica guiada por ARN y regulación génica |
| CN104878020B (zh) | 2015-04-29 | 2017-09-15 | 华中农业大学 | 一种控制水稻叶片直立性发育的基因及其应用 |
| WO2018035377A1 (en) * | 2016-08-17 | 2018-02-22 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
-
2013
- 2013-11-01 WO PCT/US2013/068118 patent/WO2014071219A1/en not_active Ceased
- 2013-11-01 CN CN201380056620.0A patent/CN104769112A/zh active Pending
- 2013-11-01 KR KR1020157013918A patent/KR102121086B1/ko active Active
- 2013-11-01 AU AU2013337651A patent/AU2013337651B2/en active Active
- 2013-11-01 CA CA2890110A patent/CA2890110C/en active Active
- 2013-11-01 CA CA3150985A patent/CA3150985A1/en active Pending
- 2013-11-01 JP JP2015540833A patent/JP6510416B2/ja active Active
- 2013-11-01 KR KR1020207015879A patent/KR102315098B1/ko active Active
- 2013-11-01 BR BR122019025681-0A patent/BR122019025681B1/pt active IP Right Grant
- 2013-11-01 EP EP13850281.0A patent/EP2914728B1/en active Active
- 2013-11-01 KR KR1020217033133A patent/KR102596302B1/ko active Active
- 2013-11-01 KR KR1020237036946A patent/KR20230154283A/ko not_active Ceased
- 2013-11-01 EP EP20184168.1A patent/EP3786298A1/en not_active Withdrawn
- 2013-11-01 MX MX2015005346A patent/MX363017B/es unknown
- 2013-11-01 RU RU2015120524A patent/RU2711249C2/ru active
- 2013-11-01 RU RU2019143431A patent/RU2019143431A/ru unknown
- 2013-11-01 BR BR122019025678-0A patent/BR122019025678B1/pt active IP Right Grant
-
2015
- 2015-04-27 MX MX2019002498A patent/MX2019002498A/es unknown
- 2015-04-30 US US14/701,199 patent/US9447395B2/en active Active
- 2015-06-10 US US14/735,603 patent/US9376669B2/en active Active
-
2016
- 2016-05-17 US US15/156,829 patent/US9487768B2/en active Active
- 2016-05-17 US US15/156,806 patent/US9464285B2/en active Active
- 2016-09-20 US US15/270,469 patent/US9657282B2/en active Active
-
2017
- 2017-04-13 US US15/487,088 patent/US9758797B2/en active Active
- 2017-08-07 US US15/670,639 patent/US10415060B2/en active Active
-
2018
- 2018-04-06 JP JP2018073676A patent/JP6890565B2/ja active Active
- 2018-04-06 JP JP2018073677A patent/JP6793146B2/ja active Active
- 2018-11-16 AU AU2018264115A patent/AU2018264115B2/en active Active
-
2019
- 2019-07-26 US US16/523,558 patent/US10590437B2/en active Active
- 2019-10-16 US US16/654,532 patent/US11339409B2/en active Active
- 2019-10-16 US US16/654,536 patent/US10752917B2/en active Active
- 2019-10-16 US US16/654,726 patent/US11339410B2/en active Active
- 2019-10-17 US US16/655,760 patent/US11332758B2/en active Active
- 2019-10-17 US US16/655,744 patent/US10724053B2/en active Active
- 2019-10-17 US US16/655,766 patent/US10767195B2/en active Active
- 2019-10-18 US US16/657,318 patent/US11332759B2/en active Active
- 2019-10-18 US US16/657,321 patent/US10752918B2/en active Active
- 2019-10-18 US US16/657,325 patent/US10752919B2/en active Active
-
2020
- 2020-06-25 US US16/912,321 patent/US12006508B2/en active Active
-
2021
- 2021-02-24 JP JP2021027831A patent/JP7436406B2/ja active Active
- 2021-10-15 AU AU2021250972A patent/AU2021250972A1/en not_active Abandoned
-
2022
- 2022-04-12 US US17/718,668 patent/US20220243228A1/en active Pending
-
2024
- 2024-02-08 JP JP2024018042A patent/JP2024056815A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018113985A5 (enExample) | ||
| Kaji et al. | Virus-free induction of pluripotency and subsequent excision of reprogramming factors | |
| Staahl et al. | Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes | |
| EP3294873B2 (en) | Targeting bcl11a enhancer functional regions for fetal hemoglobin reinduction | |
| JP2018115207A5 (enExample) | ||
| Okita et al. | Generation of germline-competent induced pluripotent stem cells | |
| RU2020104969A (ru) | Способы и продукты для получения и доставки нуклеиновых кислот | |
| JP2017035113A5 (enExample) | ||
| RU2017118312A (ru) | Способы и препараты для трансфекции клеток | |
| US20090191171A1 (en) | Reprogramming of Differentiated Progenitor or Somatic Cells Using Homologous Recombination | |
| JP2019058176A (ja) | 新規方法 | |
| CN110467679A (zh) | 一种融合蛋白、碱基编辑工具和方法及其应用 | |
| Wang | Application of modified mRNA in somatic reprogramming to pluripotency and directed conversion of cell fate | |
| Nguyen et al. | Patient-specific iPSC-derived RPE for modeling of retinal diseases | |
| CN108778299A (zh) | 生成无载体诱导多能干细胞的载体和方法 | |
| Pietronave et al. | Advances and applications of induced pluripotent stem cells | |
| WO2009092042A1 (en) | Reprogramming of differentiated progenitor or somatic cells using homologous recombination | |
| CN109486814A (zh) | 一种用于修复HBB1基因点突变的gRNA、基因编辑系统、表达载体和基因编辑试剂盒 | |
| JP7606176B2 (ja) | ゲノム編集効率を向上させる融合タンパク質及びその使用 | |
| Inagaki | Cell reprogramming and differentiation utilizing messenger RNA for regenerative medicine | |
| US20190136200A1 (en) | Cellular Reprogramming Utilizing mRNA | |
| Tian et al. | Rationale and methodology of reprogramming for generation of induced pluripotent stem cells and induced neural progenitor cells | |
| US20230272348A1 (en) | Methods of generating hematopoietic cell preparations | |
| JP7630116B2 (ja) | 変異型ｋｌｆタンパク質、及び誘導多能性幹細胞の製造方法 | |
| JP5880868B2 (ja) | 核内受容体及びその変異体、並びに細胞の再プログラミングにおけるその使用 |